We are live on ! Find out more
TLSA icon

Tiziana Life Sciences

23 hedge funds and large institutions have $13.1M invested in Tiziana Life Sciences in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more capital inflows, than outflows

Capital inflows: $1.73M | Capital outflows: $591K

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

0.49% more ownership

Funds ownership: 5.24% → 5.73% (+0.49%)

0% more funds holding

Funds holding: 23 → 23 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
6
Closed
4
Calls
$10K
Puts
–
Net Calls
+$10K
Net Calls Change
+$62K

TLSA Hedge Fund Activity: Q2 2021 in Review

23 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q2 2021, worth a combined $13.1M — down 7.5% from $14.1M a quarter earlier.

Fund positioning in TLSA was balanced in Q2 2021: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $1.39M. The largest seller was Marshall Wace, cutting an estimated $178K.

  • 23 institutional investors held Tiziana Life Sciences (TLSA) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $13.1M of Tiziana Life Sciences stock for Q2 2021, down 7.5% quarter-over-quarter.
  • 4 funds opened new Tiziana Life Sciences positions in Q2 2021 and 4 closed out, a net change of 0 holders.
  • The largest Tiziana Life Sciences buyer in Q2 2021 was BlackRock, an estimated $1.39M added.
  • The largest Tiziana Life Sciences seller in Q2 2021 was Marshall Wace, an estimated $178K sold.

Based on aggregated 13F filings for Q2 2021.